News

Cancer Research UK, the world’s leading cancer charity, and Hummingbird Bioscience, an innovative systems-biology enabled biotechnology company, have announced a partnership to develop Hummingbird’s anti-HER3 antibody drug, HMBD-001, for the treatment of people with HER3 driven cancer. Under the terms...

GSK and the Sabin Vaccine Institute (Sabin) announced exclusive agreements for Sabin to advance the development of the prophylactic candidate vaccines against the deadly Ebola Zaire, Ebola Sudan and the closely related, but lesser known, Marburg virus. No licensed...

Sale Highlights: Tank Farm & Distillation Syst. (35) Assorted Tanks-to 40,000 Liters Stainless, Plastic, Fiberglass & CS Assorted Pumps, Filters & Controls Stainless Pipework, Valves & Work Decks (2) Vapor Compression H2O Distillation Units, Manufactured by Cor Pharmaceuticals Factory Infrastructure: (2)...

Sarepta Therapeutics, Inc, the leader in precision genetic medicine for rare diseases, was informed earlier  that an adverse event report was erroneously submitted to the FDA’s adverse event reporting system (FAERs), a post-marketing surveillance database for approved therapies. Our...

Vesselon, an oncology therapeutics company, announced the acquisition of an FDA-approved drug Imagent®. Vesselon will use Imagent to create novel therapeutic complexes in four classes of cancer drugs: cytokines, oncolytic viruses, monoclonal antibodies, and nucleic acid constructs. Vesselon incorporates Imagent...

Zenith Capital Corp. announced  that Zenith Epigenetics Ltd. , a wholly-owned subsidiary of Zenith Capital, has entered into a licensing agreement with Newsoara BioPharma Co., Ltd. for the Company’s lead compound, ZEN-3694, in China, Hong Kong, Taiwan, and Macau...

Aucta Pharmaceuticals, Inc. ,a technology based company focusing on the development and commercialization of Branded Specialty Products, announced that the Company has entered into an exclusive license agreement with Jiangsu Wanbang Biopharmaceuticals Group Co., Ltd., a subsidiary of Shanghai...